Publicações

20Mo Time to Deterioration in Quality of Life in Patients (Pts) with Advanced Endometrial Cancer (Aec) Treated with Lenvatinib plus Pembrolizumab (L+P) or Treatment of Physician’s Choice (Tpc)

AuthID
P-00X-2PS

Author(s)

Lorusso, D

Colombo, N

Casado Herraez, A

Santin, A

Colomba, E

Miller, D

Fujiwara, K

Pignata, S

Baron-Hay, S

Ray-Coquard, I

Shapira-Frommer, R

Kim, Y

McCormack, M

Massaad, R

Martin Nguyen, A

Zhao, Q

McKenzie, J

Prabhu, V

Makker, V

Tipo de Documento

Article

Year published

2022

Publicado

in Annals of Oncology, ISSN: 0923-7534

Volume: 33, Páginas: S391-S392

Indexing

Crossref^®1

Google Scholar^®

Metadata
Fontes

Publication Identifiers

DOI: 10.1016/j.annonc.2022.04.038

Source Identifiers

ISSN: 0923-7534

Export Publication Metadata

Lista Marked

Adicionar à lista Marked

Info

At this moment we don't have any links to full text documens.

20Mo Time to Deterioration in Quality of Life in Patients (Pts) with Advanced Endometrial Cancer (Aec) Treated with Lenvatinib plus Pembrolizumab (L+P) or Treatment of Physician’s Choice (Tpc)

Links Úteis

Ajuda

Autenticação Federada (Clique na imagem)

20Mo Time to Deterioration in Quality of Life in Patients (Pts) with Advanced Endometrial Cancer (Aec) Treated with Lenvatinib plus Pembrolizumab (L+P) or Treatment of Physician’s Choice (Tpc)

Links Úteis

Ajuda